Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Dusseldorf - Delayed Quote EUR

Harvard Bioscience Inc (HBI.DU)

Compare
0.3340
-0.1300
(-28.02%)
At close: April 4 at 7:30:58 PM GMT+2
Loading Chart for HBI.DU
  • Previous Close 0.4640
  • Open 0.4180
  • Bid 0.3280 x --
  • Ask 0.4140 x --
  • Day's Range 0.3340 - 0.4180
  • 52 Week Range 0.3340 - 4.1600
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: HBI.DU

View More

Performance Overview: HBI.DU

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HBI.DU
81.95%
S&P 500 (^GSPC)
13.73%

1-Year Return

HBI.DU
91.16%
S&P 500 (^GSPC)
1.42%

3-Year Return

HBI.DU
94.09%
S&P 500 (^GSPC)
10.72%

5-Year Return

HBI.DU
82.87%
S&P 500 (^GSPC)
103.89%

Compare To: HBI.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HBI.DU

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    15.99M

  • Enterprise Value

    52.56M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    0.26

  • Enterprise Value/Revenue

    0.62

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: HBI.DU

View More

Company Insights: HBI.DU

Research Reports: HBI.DU

View More